JohnVargaMD
Rheumatology • Ann Arbor, MIScleroderma & Related
John and Nancy Hughes Distinguished Professor of Rheumatology, Northwestern University Medical School
Dr. Varga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000- Is this information wrong?
Summary
- I received my MD from New York University. Following Medicine residency at Rhode Island Hospital, trained in Rheumatology at Boston University, and then completed a basic research post-doc at the University of Pennsylvania
I moved to the Midwest in 1995, and joined the faculty at Northwestern University in 2004. I founded the Scleroderma Program and run a basic/translational research lab focusing on fibrosis and precision medicine
Education & Training
University of Pennsylvania Health SystemFellowship, Rheumatology, 1985 - 1987
Boston University Medical CenterFellowship, Rheumatology, 1983 - 1985
Brown UniversityResidency, Internal Medicine, 1980 - 1983
New York University School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 2020 - 2026
IL State Medical License 1995 - 2020
PA State Medical License 1985 - 1996
Awards, Honors, & Recognition
- Member Association of American Physicians
- Member AOA
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.Amanda S Pellowe, Michelle J Wu, Tae-Yun Kang, Tracy D Chung, Adrian Ledesma-Mendoza, Andre Levchenko, Anjelica L Gonzalez, Erica Herzog, Ian Odell, John Varga> ;The American Journal of Pathology. 2024 Mar 26
- Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.Feiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, Olesya Plazyo, Xianying Xing, Joseph Kirma, Rachael Wasikowski, Grace A Hile, Paul W Harms, Yanyun Jiang, Enze Xing...> ;Nature Communications. 2024 Jan 3
- 1 citationsEmerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches.Alain Lescoat, Hiroshi Kato, John Varga> ;Current Opinion in Rheumatology. 2023 Nov 1
- Join now to see all
Journal Articles
- Emerging Targets of Disease-Modifying Therapy for Systemic SclerosisElizabeth R Volkmann, John Varga, Nature
- Adipocyte-Specific Repression of PPAR-Gamma by NCoR Contributes to Scleroderma Skin FibrosisWarren Tourtellotte, Benjamin Korman, John Varga, BioMed Central
Other
- Pulmonary vascular disease in systemic sclerosis (scleroderma): TreatmentVarga J, Steen V
http://www.uptodate.com/contents/pulmonary-vascular-disease-in-systemic-sclerosis-scleroderma-treatm
UpToDate, Wolters Kluwer Health - 2012-04-23 - Scleroderma renal crisisVarga J, Fenves A
http://www.uptodate.com/contents/scleroderma-renal-crisis
UpToDate, Wolters Kluwer Health - 2013-04-12 - Eosinophilic fasciitisVarga J, Helfgott SM
http://www.uptodate.com/contents/eosinophilic-fasciitis
UpToDate, Wolters Kluwer Health - 2012-09-14 - Join now to see all
Press Mentions
Could Getting Rid of Old Cells Turn Back the Clock on Aging?January 2nd, 2023- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- PLG Nanoparticles Inhibit Skin and Lung Fibrosis by Targeting MARCO+ CellsMarch 8th, 2022
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Northwestern Memorial HospitalChicago, Illinois
University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
